文献速递自身炎症与 IgG4 相关病

日本人群IgG4相关病的全基因组测序研究

IgG4-related disease in the Japanese population: a whole-genome sequencing study.
PubMed 文献 · Lancet Rheumatol · 2025-11-03

该研究采用全基因组测序在日本人群中开展两套分亚型病例对照关联分析,验证FCGR2B为易感位点,确认HLA氨基酸残基DRB1-GB-7等与IgG4相关病相关,发现C4拷贝数变异及Mikulicz病特异性位点PTCH1和LOC102724227。

核心结论

  • C4拷贝数变异与HLA及FCGR2B共同构成IgG4相关病的遗传易感因素,体现该病的复杂多基因特征。
  • PTCH1和长链非编码RNA LOC102724227为Mikulicz病特异性易感位点,提示遗传异质性可能解释IgG4相关病的临床多样性,尤其与受累器官相关。

研究设计与样本

  • 采用全基因组测序在日本人群中开展两套分亚型病例对照关联研究。
  • 全基因组测序深度为15×或30×,使用HiSeqX和NovaSeq平台(Illumina),并采用基于读深的分型方法分析补体C4拷贝数变异。
  • 所有个体均为本州日本人 ancestry;病例和对照未施加特定纳入或排除标准。

临床怎么用

  • 本研究鉴定的FCGR2B、HLA氨基酸残基及C4拷贝数变异等遗传因素与IgG4相关病易感性相关,可供临床认识该病遗传背景参考。
  • PTCH1和LOC102724227为Mikulicz病特异性易感位点,提示遗传异质性可能与IgG4相关病器官受累多样性相关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: IgG4-related disease is a rare autoimmune disorder characterised by tissue infiltration of IgG4-positive plasma cells, storiform fibrosis, elevated serum IgG4 concentrations, and increased risk of tumour complications. Previous genetic studies have implicated FCGR2B and HLA loci in susceptibility to IgG4-related disease; however, most relied on microarray-based genotyping and imputation, which have limited resolution in highly polymorphic and structurally complex regions. This study aimed to investigate genetic susceptibility to IgG4-related disease using comprehensive genomic variant analysis, including low-frequency and structural variants not readily captured by microarrays. METHODS: We conducted a genome-wide association study using whole-genome sequencing data in a two-set, subtype-stratified case-control design in the Japanese population. Set 1 included samples (cases) from patients with IgG4-related disease from 50 hospitals across Japan participating in the Japanese IgG4-related disease Working Consortium (recruited between Oct 27, 2008, and March 3, 2016) and previously sequenced Japanese population control samples. Set 2 included samples (cases) from patients with IgG4-related disease from eight hospitals of the Consortium (recruited between Aug 12, 2021, and Dec 20, 2023) and previously sequenced healthy individuals residing in the Tokyo metropolitan area (controls). No specific inclusion or exclusion criteria were applied to either cases and controls. We used whole-genome sequencing at depths of 15× or 30× using HiSeqX and NovaSeq platforms (Illumina; San Diego, CA, USA) to enable the inclusion of previously uncaptured single nucleotide polymorphisms and direct analysis of HLA amino acid residues. We investigated complement component 4 copy number variations using short-read sequencing data and established read-depth-based typing methods. People with lived experience of IgG4-related disease were not involved in the study. FINDINGS: This whole-genome sequencing study comprised of 2 sets. Set 1 included 646 patient samples (172 [26·6%] were female, 474 [73·4%] were male, and the mean age was 64·4 years [SD 11·4]) and 2254 population controls (1348 [59·8%] were female and 906 [40·2%] were male). Set 2 included 223 patient samples (78 [35·0%] were female, 145 [65·0%] were male, and the mean age was 63·5 years [10·9]) and 405 population controls (65 [16·0%] were female and 340 [84·0%] were male). All individuals were of Hondo Japanese ancestry. The average IgG4 concentration at diagnosis was 653·1 mg/dL (SD 596·3) in Set 1 and 543·5 mg/dL (603·5) in Set 2. We validated the FCGR2B (p=9·8 × 10-11) region as the susceptibility locus for IgG4-related disease. PTCH1 (p=3·8 × 10-8) and long non-coding RNA LOC102724227 were found to be specific susceptibility loci for Mikulicz's disease. We also confirmed the association between the HLA amino acid residue DRB1-GB-7 (p=1·1 × 10-19) with IgG4-related disease and identified two additional residues, A-GA2-9 (p=4·1 × 10-6) and DQB1-GB-82 (p=4·7 × 10-9), that were significantly associated with IgG4-related disease. In the joint-association analysis of complement component 4 copy number variation, C4A showed a protective association with IgG4-related disease (β=-0·127, p=7·9 × 10-3), whereas C4B was associated with an increased risk (β=0·151, p=1·9 × 10-2). A low level of linkage disequilibrium (r2<0·15) was observed between the C4A and C4B alleles and the identified HLA amino acid residues in the main island Japanese population. INTERPRETATION: C4 copy number variation, in addition to HLA and FCGR2B, was found to be a distinct genetic factor associated with IgG4-related disease susceptibility, illustrating the complex polygenic nature of the disease. Furthermore, the identification of PTCH1 and the long non-coding RNA LOC102724227 as Mikulicz's disease-specific susceptibility loci suggests that genetic heterogeneity might underlie the clinical diversity of IgG4-related disease, particularly with respect to the affected organs. FUNDING: The Japanese Ministry of Health, Labour, and Welfare, the Japanese Agency of Medical Research and Development, the Kyoto University Grant for Top Global University Japan Project, and the Kyoto University Division of Graduate Studies SPRING Program.

来源:Lancet Rheumatol,查看原文。版权归原作者所有。

引用

  1. Zhang YO, Iwasaki T, Kawaguchi T, et al. IgG4-related disease in the Japanese population: a whole-genome sequencing study. Lancet Rheumatol. 2025. PMID: 41197642. doi:10.1016/S2665-9913(25)00195-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。